Revolutionary Brain Receptor Insights Promise Next-Gen Mental Health Drugs
Researchers at Mount Sinai have uncovered detailed molecular insights into the 5-HT1A serotonin receptor, revealing how it interacts with G proteins and drugs, which could lead to the development of faster, more targeted mental health treatments with fewer side effects.